# A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma

> **NCT00130351** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 155 (actual)

## Conditions studied

- Asthma

## Interventions

- **DEVICE:** formoterol

## Key facts

- **NCT ID:** NCT00130351
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2005-08
- **Final completion:** 2005-08
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2023-05-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00130351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00130351, "A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00130351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*